Saturday, November 6, 2021
- 8:30AM-10:30AM
-
Abstract Number: 0419
Post-induction ANCA Titer Does Not Predict Mortality or Renal Outcomes: A Target Trial Emulation Study
Vasculitis – ANCA-Associated Poster (0414–0436)- 8:30AM-10:30AM
-
Abstract Number: 0076
Predicting the Transitions Between Lupus Anticoagulant Status and Thrombosis in SLE Using a Multi-state Markov Model
Antiphospholipid Syndrome Poster (0069–0083)- 8:30AM-10:30AM
-
Abstract Number: 0388
Prediction Tool for Damage Accrual Trajectory in Incident Systemic Sclerosis
Systemic Sclerosis & Related Disorders – Clinical Poster I (0387–0413)- 8:30AM-10:30AM
-
Abstract Number: 0387
Predictors for Progressive Fibrosis in Patients with Connective Tissue Disease Associated Interstitial Lung Diseases
Systemic Sclerosis & Related Disorders – Clinical Poster I (0387–0413)- 8:30AM-10:30AM
-
Abstract Number: 0413
Predictors of ILD Development and Timing of Onset in Systemic Sclerosis: A Canadian Cohort
Systemic Sclerosis & Related Disorders – Clinical Poster I (0387–0413)- 8:30AM-10:30AM
-
Abstract Number: 0070
Pregnancy Outcomes of Antiphospholipid Antibody Positive Patients: Prospective Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
Antiphospholipid Syndrome Poster (0069–0083)- 8:30AM-10:30AM
-
Abstract Number: 0290
Prevalence and Predictors of Mortality in Rheumatoid Arthritis-Related Lung Disease: Results from a Single Center Study
RA – Diagnosis, Manifestations, & Outcomes Poster I: Cardiovascular Pulmonary Disease (0268–0295)- 8:30AM-10:30AM
-
Abstract Number: 0126
Prevalence of Dyslipidemia in Fibromyalgia: A Single Center Case Control Study from South India
Fibromyalgia & Other Clinical Pain Syndromes Poster (0118–0127)- 8:30AM-10:30AM
-
Abstract Number: 0225
Prevalence of Sexual Dysfunction and Depression in German Patients with Psoriasis and Psoriatic Arthritis – Results of the PIPPA Study
Patient Outcomes, Preferences, & Attitudes Poster I: Impact (0225–0240)- 8:30AM-10:30AM
-
Abstract Number: 0332
Prevalence of Systemic Lupus Erythematosus in the United States: Updated Population Representative Estimates from the Medical Expenditure Panel Survey (MEPS) 2016-2018
SLE – Diagnosis, Manifestations, & Outcomes Poster I: Diagnosis (0323–0356)- 8:30AM-10:30AM
-
Abstract Number: 0412
Prevalence, Distribution, Clinical Correlates and Outcomes of Upper Extremity Macrovascular Disease in Systemic Sclerosis: Results from a Single Center Referral Cohort (2001-2018)
Systemic Sclerosis & Related Disorders – Clinical Poster I (0387–0413)- 8:30AM-10:30AM
-
Abstract Number: 0064
Prevalence, Incidence and Predictor Features of Uveitis in Spondyloarthritis in a Canadian Cohort
Spondyloarthritis Including PsA – Basic Science Poster (0046–0068)- 8:30AM-10:30AM
-
Abstract Number: 0312
Prognostic Value of Salivary Gland Ultrasonography in Primary Sjögren’s Syndrome